All Pharma News
price-trendAsk Us
Imbrium Completes First Patient Visit in Ph1 Study of Potential Treatment

Imbrium Completes First Patient Visit in Ph1 Study of Potential Treatment
BUSINESSWIRE
20 Dec 2022
Share Share
Imbrium Therapeutics Presents Results of a Phase 2 Study of Sunobinop

Imbrium Therapeutics Presents Results of a Phase 2 Study of Sunobinop
BUSINESSWIRE
12 Dec 2022
Share Share
Purdue subsidiary buys non-opioid pain prospect

Purdue subsidiary buys non-opioid pain prospect
N. P. Taylor FIERCEBIOTECH
12 Aug 2021
Share Share
Imbrium Presents First Data and Describes Novel Mechanism of Action For IMB-115

Imbrium Presents First Data and Describes Novel Mechanism of Action For IMB-115
MARKETS
28 Aug 2020
Share Share
Imbrium Therapeutics L.P Announce 1st Patient Dosed in Phase 1/2 Clinical Study

Imbrium Therapeutics L.P Announce 1st Patient Dosed in Phase 1/2 Clinical Study
BUSINESS WIRE
26 Nov 2019
Share Share